Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -18.874% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCCc1nc(NCCO)c(C#N)c2c1CCCC2
b CCOC(=O)c1cnc2ccc(Cl)cc2c1Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1
c COc1ccc(CC2(CO)CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1
Answer: a. CCCc1nc(NCCO)c(C#N)c2c1CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1nc(NCCO)c(C#N)c2c1CCCC2
CCCc1nc(NCCO)c(C#N)c2c1CCCC2
3-(2-hydroxyethylamino)-1-propyl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile